Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1( L ) ASCORBATO DI CALCIO1件: Calcium---2件: 96, 97
2(+) erythromefloquine----1件: 46
3(+) isomer of racemic mefloquine1件: Mefloquine1件: D04895 --1件: 46
4(+) isomer or racemic mefloquine1件: Mefloquine1件: D04895 --1件: 46
5(+)- Epicatechin1件: Epicatechin---1件: 113
6(+)-(S)-2-(6-methoxynaphthalen-2-yl) propanoic acid2件: Naproxen,
Propanoic acid		1件: D00118 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271
7(+)-Epicatechin1件: Epicatechin---1件: 113
8(+)erythromefloquine----1件: 46
9(-)-3-(4-Aminophenyl)-2-methoxypropionic acid----1件: 97
10(-)-Epicatechin1件: Epicatechin---2件: 86, 113
11(-)-trans-delta-9-Tetrahydrocannabinol1件: Dronabinol1件: D00306 2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13
12(1-13C) Sodium Acetate2件: Acetate,
Sodium acetate		1件: D01779 --1件: 251
13(1-3)-beta-D-Glucan (BDG) assay (Fungitell)----1件: 107
14(1-3)-ß-D-Glucan (BDG) assay (Fungitell)----1件: 107
15(11C)PE2I----1件: 6
16(18)F-FDG----1件: 85
17(18F)FPGLU----1件: 86
18(1R,3S,5R)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide----1件: 11
19(2)-epigallocatechin-3-gallate (EGCG)2件: Epigallocatechin,
Epigallocatechin gallate		---1件: 8
20(2-chloro-5-[11C]methoxy-N-(((3s,5s,7s)-3,5,7-trifluoroadamantan-1-yl)methyl) benzamide)----1件: 6
21(2R)-2-Propyloctanoic acid1件: Arundic acid1件: D06296 --1件: 2
22(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-y1] butanamide----1件: 309
23(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide----1件: 309
24(3beta, 5beta, 25R)-spirostan-3-ol----1件: 6
25(3R,4R)-4-methyl-3-(methyl-1H-pyrrolo [2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-----1件: 46
26(3R,4R)-4-methyl-3-(methyl-1H-pyrrolo [2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile,----1件: 46
27(3R,4R)-4-methyl-3-(methyl-1H-pyrrolo [2,3-d]pyrimidin-4-ylamino)-ß-oxo-1-----1件: 46
28(3R,4R)-4-methyl-3-(methyl-1H-pyrrolo [2,3-d]pyrimidin-4-ylamino)-ß-oxo-1-piperidinepropanenitrile,----1件: 46
29(3R,4R)-4-metil-3-(metil-1H-pirrolo [2,3-d]pirimidin-4-ilamino)-beta-oxo-1-----1件: 46
30(3R,4R)-4-metil-3-(metil-1H-pirrolo [2,3-d]pirimidin-4-ilamino)-ß-oxo-1-----1件: 46
31(3ß, 5ß, 25R)-spirostan-3-ol----1件: 6
32(4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydropyrimidine-5-carbonitrile----1件: 231
33(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[4’-----1件: 79
34(6R)-4, 5, 6, 7 - tetrahydro-N6-propyl-2,6-benzothiazolidiamine dihydrochloride monohydrate----1件: 2
35(6S)-6-{propyl-[2-[2-thienyl]ethyl]amino}-5,6,7,8-tetrahydro-1-naphtalenol----1件: 6
36(7R,8R,9R)-2.3-Dimethyl-8-hydroxy-7(2-methoxyethoxy)- 9-phenyl-7.8.9.10-tetrahydro-imidazo-[1.2-h].[1.7].- naphthyridine----1件: 301
37(CDP6038----1件: 46
38(E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime----1件: 161
39(IM) AVONEX®1件: Interferon beta-1a1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
40(minus)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate----1件: 6
41(Pyr1)apelin-13----1件: 86
42(R) 3-(5-Dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1- methylethyl) benzamide----1件: 13
43(R)-(-)-2-Propyloctaroic acid----1件: 2
44(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-1件: Pyrazole---1件: 75
45(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-4,4A,5,6,7,8-HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN-4A-YL)(4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE1件: Pyrazole---1件: 75
46(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)4,4A,5,6,7,8-HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN-4A-YL)(4(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE1件: Pyrazole---1件: 75
47(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4YL)SULFONYL)4,4A,5,6,7,8HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN4AYL)(4(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE1件: Pyrazole---1件: 75
48(R)-3-(1-oxo-propoxy)-4-(N,N,N-trimethyl amonium chloride)-butanoic acid2件: Butyric Acid,
Chloride ion		---1件: 97
49(R)-[N-metil-11C1-PK11195(PK)----1件: 127
50(R)-N-(5-(5-ETHYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-1-METHYL-1H-PYRAZOLE-4-CARBOXAMIDE1件: Pyrazole---1件: 58
51(R)-N-(5-(5-ETHYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-1METHYL-1H-PYRAZOLE-4-CARBOXAMIDE1件: Pyrazole---1件: 58
52(R)-N-(5-(5-ETHYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-1METHYL-1HPYRAZOLE-4-CARBOXAMIDE----1件: 58
53(R)-tetrahydrofuran-3-yl 4-(6-(5-(4-ethoxy-1-isopropylpiperidin-4- yl)pyridine-2-yl)pyrrolo[1,2-b]pyridazin-4-yl)piperazine-1-carboxylate sesquisuccinate1件: Piperazine1件: D00807 --1件: 272
54(R)-tetrahydrofuran-3-yl 4-(6-(5-(4-ethoxy-1-isopropylpiperidin-4- yl)pyridine-2yl)pyrrolo[1,2-b]pyridazin-4-yl)piperazine-1-carboxylate1件: Piperazine1件: D00807 --1件: 272
55(R)-troloxamide quinone----1件: 6
56(RS)-baclofen1件: Baclofen1件: D00241 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 10
57(RS)-baclofen, naltrexone hydrochloride and D-sorbitol3件: Baclofen,
Naltrexone,
Sorbitol		3件: D00096 ,
D00241 ,
D05113 		5件: GABBR1,
GABBR2,
OPRD1,
OPRK1,
OPRM1 💬		9件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 10
58(S)- 2- Amino- 4,5,6,7- tetrahydro- 6- (propylamino)benzothiazol----1件: 6
59(S)-(+)-2-(4-(3-fluorobenzyl)oxybenzyl)aminopropanamide methanesulfonate----1件: 6
60(S)-(-)-3-(4-Aminophenyl)-2-methoxypropionic Acid----1件: 97
61(S)-2-(4,6-dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid----1件: 86
62(S)-2-amino-6-(2-hydroxypropanoyl)-7,8-dihydropteridin-4(3H)-one----1件: 240
63(S)-3-((3-(1-((6-(3,4-DIMETHOXYPHENYL)PRYAZIN-2- YL)AMINO)ETHYL)PHENYL)CARBAMOYL)-5-METHYLPRIDIN-1-IUM----1件: 86
64(S)-3-((3-(1-((6-(3,4-DIMETHOXYPHENYL)PRYAZIN-2-YL)AMINO)ETHYL)PHENYL)CARBAMOYL)-5-METHYLPRIDIN-1-IUM----1件: 86
65(S)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazo----1件: 284
66(S)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide3件: Hydroxide ion,
Magnesium,
Magnesium hydroxide		1件: D00731 --1件: 284
67(S)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-m----1件: 284
68(S)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide3件: Hydroxide ion,
Magnesium,
Magnesium hydroxide		1件: D00731 --1件: 284
69(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5- yl)-2-isopropoxybenzonitrile hydrochloride----1件: 97
70(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxyben----1件: 97
71(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile hydrochloride----1件: 97
72* D.3.4 Solution for infusion in pre-filled syringe----1件: 97
73* D.3.4 Solution for injection in pre-filled syringe----1件: 97
74* D.3.4 Solution for injection/infusion in pre-filled syringe----1件: 97
75* D.3.6.2.1 - valore : Every 4 weeks dosing of 200 mg----1件: 41
76* D.3.6.2.1 - valore :Every 4 weeks dosing of 400 mg----1件: 41
77**Comment**- IMP inhalation solution identical to ventavis inhalation solution, but IMP is in a different volume presentation. Please see covering letter.1件: Iloprost1件: D02721 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
78-aminosalicylic acid1件: Aminosalicylic acid1件: D00162 --2件: 96, 97
79.Nusinersen1件: Nusinersen1件: D10881 1件: SMN2 💬-1件: 3
800 mg Prednisone1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 44
810 mg tropicamide1件: Tropicamide1件: D00397 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6
820,25 mg RPC1063----1件: 96
830,5 mg Fingolimod1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
840,5 mg Prevenar i.m.----1件: 51
850,5 mg seasonal influenza vaccine i.m.----1件: 51
860.005% Lacripep----1件: 53
870.01% Lacripep----1件: 53
880.02% Fm, SH----1件: 53
890.02% Fm, SH, 0.05% CsA----1件: 53
900.02% Fm, SH, AS----1件: 53
910.04 mg Lu AE04621----1件: 6
920.05%cyclosporin eye drop1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 38
930.08 mg Lu AE04621----1件: 6
940.12% saline----1件: 299
950.15mg KPG-818 dose----1件: 49
960.2 mg Lu AE04621----1件: 6
970.25 mg RPC103----1件: 97
980.25 mg RPC1063----3件: 13, 96, 97
990.25mg RPC103----1件: 97
1000.25mg RPC1063----2件: 13, 97
1010.3 mg tropicamide1件: Tropicamide1件: D00397 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6
1020.4 mg Lu AE04621----1件: 6
1030.4mL prefilled syringes----1件: 107
1040.5 mg budesonide effervescent tablet for orodispersible use1件: Budesonide1件: D00246 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98
1050.5 mg RPC1063----2件: 13, 97
1060.5% marcaine----1件: 70
1070.5mg RPC1063----1件: 13
1080.6 mg Lu AE04621----1件: 6
1090.6mg KPG-818 dose----1件: 49
1100.7mL prefilled syringes----1件: 107
1110.8 mg Lu AE04621----1件: 6
1120.9% Isotonic Saline (IS)----1件: 299
1130.9% Isotonic Saline (IS), 4mL----1件: 299
1140.9% normal saline (control)----1件: 299
1150.9% physiological saline----1件: 266
1160.9% saline----2件: 6, 70
1170.9% sodium chloride2件: Chloride ion,
Sodium chloride		1件: D02056 --4件: 6, 14, 51, 53
1180.9% sodium chloride (normal saline)2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 6
1190.9% Sodium Chloride Injection2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 168
1200.9% w/v isotonic sodium chloride solution2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 50
1210.9% w/v sodium chloride solution2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 299
1220000----1件: 3
12300000----2件: 6, 96
124000000----1件: 6
125000000000----1件: 66
1260002-8971----1件: 70
12700070500----1件: 60
12800201600----1件: 229
12900244301----1件: 274
13000258901----1件: 85
13100305800----2件: 53, 160
13200319301----1件: 60
13300322900----1件: 85
134009-0----1件: 6
135009-1----1件: 6
136009-2----1件: 6
137009-3----1件: 6
138009-4----1件: 6
139009-5----1件: 6
140009-A0----1件: 6
141009-A1----1件: 6
142009-A2----1件: 6
143009-A3----1件: 6
1440109-0012A 100 mg/ml----1件: 46
1450109-0012A 25 mg/ml----1件: 46
1460109-0012A 50 mg/ml----1件: 46
1470114-0006B----2件: 46, 96
148023145028----1件: 6
149026863100----1件: 78
150032166011----1件: 13
151033283045----1件: 13
152033841----1件: 299
153034091165----1件: 13
154035418060----1件: 13
155043906039----1件: 6
156045251016----1件: 19
1570881----2件: 46, 271
1580C23----1件: 67
1591 - Andrographis paniculata p/st extract----1件: 13
1601 mg budesonide effervescent tablet for orodispersible use1件: Budesonide1件: D00246 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98
1611 mg QD to 15 mg QD PF-066497511件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
1621 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study)1件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
1631 mg RPC1063----2件: 13, 97
1641 mg tropicamide1件: Tropicamide1件: D00397 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6
1651 mg/kg CNTO 136----1件: 49
1661 ml 0.9 % NaCl----1件: 46
1671 Serving of broccoli sprouts1件: Broccoli---1件: 97
1681% lignocaine1件: Lidocaine2件: D00358 ,
D08127 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 84
1691% Steroid Cream----1件: 13
1701) Inosine 5'-monophosphate1件: Inosine1件: D00054 --1件: 17
1711,2-Dihexadecanoyl-sn-Glycero-3-Phospho-(1-raac-glycerol)1件: Glycerin1件: D00028 --1件: 79
1721,5 (Butylimino)-1,5-dideoxy-D-glucitol1件: Sorbitol1件: D00096 --1件: 299
1731,5-anhydro-2,3-dideoxy-3-[[(1R,3S)-3-[[7,8-dihydro-3- (trifluoromethyl)-1,6-naphthyridin-6(5H)-yl]c----1件: 46
1741- Deoxygalactonojirimycin----1件: 19
1751-(2,3,4-Trimethoxybenzyl)piperazine dihydrochloride1件: Piperazine1件: D00807 --1件: 58
1761-(2-Isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d] pyrimidin-4-one----1件: 17
1771-(6-BENZOTHIAZOLYLSULFONYL)-5-CHLORO-1H-INDOLE-2-BUTANOIC ACID2件: Butyric Acid,
Indole		---1件: 51
1781-20190----1件: 93
1791-22460----1件: 51
1801-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline carboxylic acid----1件: 299
1811-Deoxygalactonojirimycin1件: Migalastat1件: D10359 --1件: 19
1821-deoxygalactonojirimycin hydrochloride1件: Migalastat1件: D10359 --1件: 19
1831-deoxynojirimycin1件: Duvoglustat1件: D09605 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1841-deoxynojirimycin hydrochloride1件: Duvoglustat1件: D09605 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1851-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl}-2-pyrrolidinone----1件: 13
1861. Tesofensine (NS 2330)1件: Tesofensine---1件: 6
1871.0 mg Lu AE04621----1件: 6
1881.0 mg rasagiline mesylate1件: Rasagiline2件: D08469 ,
D10829 		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6
1891.0 mg RPC103----1件: 97
1901.0 mg RPC1063----1件: 97
1911.0 MIU IL-2 per day1件: Human interleukin-2---1件: 2
1921.0mg RPC1063----1件: 13
1931.2 mg Lu AE04621----1件: 6
1941.2 mg ZGN-440 for injectable suspension----1件: 193
1951.8 mg ZGN-440 for injectable suspension----1件: 193
1961.Remicade1件: Infliximab1件: D02598 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97
19710 mg----1件: 96
19810 mg Natura-alpha capsule----1件: 97
19910 mg/kg CNTO 136----1件: 49
20010 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP)1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
20110% intravenous immunoglobulin (IVIg)1件: Human immunoglobulin G---1件: 14
20210% liquid formulation of human immunoglobulin----1件: 14
20310% Metronidazole Ointment1件: Metronidazole1件: D00409 --1件: 96
20410% nifedipine cream1件: Nifedipine1件: D00437 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 50
20510% Nitroglycerine in Propylene Glycol, USP2件: Nitroglycerin,
Propylene glycol		2件: D00078 ,
D00515 		--1件: 51
20610-mg dose of E5501 2G tablet----1件: 63
20710-mg dose of E5501 cyclodextrin oral solution----1件: 63
20810-mg dose of E5501 lipid-based oral----1件: 63
20910-mg dose of E5501-P21% powder----1件: 63
21010-nitro-9(E)-octadec-9-enoic acid----1件: 86
211100----2件: 6, 97
212100 mg----1件: 97
213100 mg AP1189----2件: 46, 222
214100 mg ELX (VX-445) / 50 mg TEZ / 75 mg IVA FDC----1件: 299
215100 mg ELX /50 mg TEZ /75 mg IVA FDC----1件: 299
216100 mg ELX/50 mg TEZ /75 mg IVA FDC----1件: 299
217100 mg ELX/50 mg TEZ/75 mg IVA fixed dose combination----1件: 299
218100 mg LX3305 QD----1件: 46
219100 mg TEZ/150 mg IVA FDC----1件: 299
220100 mg VX-445 /50 mg TEZ/75 mg IVA FDC----1件: 299
221100 mg VX-445/50 mg TEZ /75 mg IVA FDC----1件: 299
222100 mg/m2 dose----1件: 299
223100 µg Brimonidine Tartrate Implant1件: Brimonidine1件: D07540 3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90
224100-mg ELX (VX-445) / 50-mg TEZ / 75-mg IVA FDC----1件: 299
225100-mg ELX (VX-455) / 50-mg TEZ / 75-mg IVA FDC----1件: 299
226100-mg ELX / 50-mg TEZ / 75 -mg IVA FDC----1件: 299
227100-mg VX-445 / 50-mg TEZ / 75- mg IVA FDC----1件: 299
228100-mg VX-445 / 50-mg TEZ / 75-mg IVA FDC----1件: 299
229100-mg VX-445 /50-mg TEZ/75-mg----1件: 299
230100-mg VX-445/50-mg TEZ/75-mg IVA FDC----1件: 299
2311000 IU D3----1件: 96
23210000IU vitamin D1件: Vitamin D---1件: 13
2331000mg RTX Group----1件: 46
234100g ELX / 50mg TEZ / 75mg IVA----1件: 299
235100mcg rhPTH(1-84)1件: Parathyroid hormone1件: D05364 2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235
236100mg ELX/50mg TEZ /75mg IVA----1件: 299
237100mg VX-445/50mg TEZ /75mg IVA FDC----1件: 299
23811-beta-hydroxysteroid dehydrogenase type 1----1件: 75
23911-ß-hydroxysteroid dehydrogenase type 1----1件: 75
240111JC101----1件: 25
241118-42-3----1件: 46
24211C-ACETATE2件: Acetate,
Acetic acid C-11		---4件: 6, 13, 86, 88
24311C-BMS-986196----1件: 13
24411C-CSar----2件: 93, 94
24511C-flumazenil1件: Flumazenil1件: D00697 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 206
24611C-MC1----1件: 6
24711C-MCI----1件: 13
24811C-PBR28----2件: 6, 13
24911C-PiB----2件: 6, 13
25011C-PS13----2件: 6, 13
25111C-Raclopride1件: Raclopride---1件: 6
25211C]-methionine1件: Methionine1件: D00019 --1件: 34
25311C]-PK-11195----1件: 13
25411C]flumazenil1件: Flumazenil1件: D00697 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 13
25511C]PBR28----1件: 6
25611C]SMW139----1件: 6
25712 mg/kg GSK2402968----1件: 113
258120 mg sodium nitrite inhalation solution1件: Nitrite---1件: 86
259124I-AT03----1件: 28
260124I-labeled monoclonal antibody Mu 11-1F4----1件: 28
261124I-p5+14 Injection----1件: 28
262125----1件: 6
263129Xe Hyperpolarized----1件: 86
26412S-IT----1件: 19
26513 valent conjugated pneumococcal vaccine----1件: 265
26613-15mg/kg/d Ursodeoxycholic----1件: 93
26713-PCV Booster----1件: 13
26813-valent pneumococcal conjugate vaccine----2件: 46, 53
26913-valent pneumococcal conjugate vaccine (13-PCV)----1件: 13
27013-valent pneumococcal conjugated vaccine (PCV13)----1件: 96
2711393641-34-3----1件: 13
27213N-Ammonia1件: Ammonia1件: D02916 --1件: 6
27313N-Amonia----1件: 6
27413NH3 PET/CT scan----1件: 84
275146368----1件: 271
27614C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration----3件: 13, 96, 97
27715 mg fampridine-SR (4-aminopyridine, 4-AP)1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
27815 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD1件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
27915 mg QD PF-066497511件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
28015 mg sodium nitrite inhalation solution1件: Nitrite---1件: 86
28115 or 45 mg----1件: 67
28215-0 H20----2件: 6, 19
28315-O labeled water1件: Water1件: D00001 --1件: 46
284150 mg double-blinded secukinumab1件: Secukinumab1件: D09967 1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 271
285150 mg GSK1265744B----1件: 265
286150 mg Induction/Chronic----1件: 97
287150 mg LX3305 QD----1件: 46
288150 mg open-label secukinumab1件: Secukinumab1件: D09967 1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 271
289150-mg IVACAFTOR1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
2901500mg mesalazine pellets1件: Mesalazine1件: D00377 --1件: 97
291150mg CXA-101件: CXA-10---1件: 86
292150mg IVACAFTOR1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
29315N ammonium chloride (15NH4Cl)2件: Ammonium chloride,
Chloride ion		1件: D01139 --1件: 251
29415N2-tofacitinib1件: Tofacitinib1件: D09970 4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 97
29515O H2O----1件: 6
29615O]H2O----1件: 6
29716,5% Cutaquig----1件: 65
2981639325-43-1----1件: 254
2991643368-58-4----2件: 53, 160
30017,21-Dihydroxypregna-1,4-diene-3,11,20-trione----1件: 41
301171----1件: 86
30217beta-hydroxy-11beta-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one----1件: 75
30317ß-hydroxy-11ß-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one----1件: 75
30418 FDG----1件: 145
30518-22mg/kg/d Ursodeoxycholic----1件: 93
30618-F]DPA-714----1件: 127
30718-FDTBZ----1件: 6
30818F florbetaben1件: Florbetaben (18F)---1件: 6
30918F- DTBZ----1件: 6
31018F-AV-1331件: Florbenazine F-18---1件: 6
31118F-AV-1451----3件: 5, 7, 127
31218F-AV-45----2件: 6, 127
31318F-DOPA----2件: 6, 75
31418F-DOPA PET----1件: 6
31518F-DPA-714 and 18F-FDG1件: Fludeoxyglucose (18F)---1件: 13
31618F-DTBZ----1件: 6
31718F-DTBZ AV-133----1件: 6
31818F-FDG1件: Fludeoxyglucose (18F)---8件: 5, 6, 7, 13, 84, 85, 127, 300
31918f-florbetaben----1件: 6
32018F-Fluoro-L-dopa1件: Levodopa1件: D00059 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
32118F-fluorodeoxyglucose----1件: 84
32218F-FSPG1件: Florilglutamic acid F-18---1件: 84
32318F-FTC-146----1件: 206
32418F-OP-801----1件: 2
32518F-PBR06----1件: 17
32618F-PM-PBB3----1件: 13
32718F-RO6958948----3件: 5, 7, 127
32818F] LBT-999----1件: 6
32918F]-(E)-N-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane----1件: 6
33018F]DPA-714----2件: 13, 127
33118F]FE-PE2I----1件: 6
33218F]Fluoride----1件: 271
33318F]MC225----1件: 6
33418F]PEG-Folate1件: Folic acid1件: D00070 --2件: 41, 46
33518FDG PET/CT scan----1件: 84
33619 nor vitamin d1件: Vitamin D---1件: 13
3371[(6- Allyl- 8beta- erg----1件: 6
3381[(6- Allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-----1件: 6
3391[(6- Allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea----1件: 6
3401[(6- Allyl- 8ß- erg----1件: 6
3411[(6- Allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-----1件: 6
3421[(6- Allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea----1件: 6
3431H-Pyrazol1件: Pyrazole---5件: 2, 28, 46, 75, 154
3441mg budesonide effervescent tablet for orodispersible use1件: Budesonide1件: D00246 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98
3451mg RPC1063----1件: 96
3461mg/kg/hr TXA intravenous infusion till the last suture----1件: 70
3471mL prefilled syringes----1件: 107
3482 - Excipients----1件: 13
3492 mg perampanel1件: Perampanel1件: D08964 4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬		16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 6
3502 million hMSC/kg----1件: 46
3512 x 10 mg Natura-alpha capsules----1件: 97
3522% Chlorhexidine solution wipes1件: Chlorhexidine1件: D07668 --1件: 299
3532% lignocaine1件: Lidocaine2件: D00358 ,
D08127 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 84
3542% sodium chondroitin sulfate2件: Chondroitin sulfate,
Sulfate ion		---1件: 226
3552',4'-difluoro-4-hydroxy-3-biphenylcarboxylic acid----1件: 28
3562'-Fucosyllactose----2件: 96, 97
3572'-O-(2-METHOXYETHYL)-D-RIBOSE ANTISENSE OLIGONUCLEOTIDE TARGETING1件: Ribose---1件: 131
3582'-O-(2-METHOXYETHYL)-D-RIBOSE ANTISENSE OLIGONUCLEOTIDE TARGETING GLIAL FIBRILLARY ACIDIC PROTEIN MESSENGER RIBONUCLEIC ACID1件: Ribose---1件: 131
3592(S)-(ACETYLAMINO)-4-METHYLPENTANOIC ACID----2件: 19, 65
3602,3-dihydroxybutanedioic acid----1件: 299
3612,5-Dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine-1-oxide----1件: 6
3622-(((2E)-3-(3-methoxy-4-(2-propyn-1-yloxy)phenyl)-1-oxo-2-propen-1-yl)amino)benzoic acid1件: Benzoic acid1件: D00038 --1件: 51
3632-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate ester----1件: 13
3642-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylat----1件: 28
3652-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylate----1件: 28
3662-(4-[5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy)-N-(methylsulfonyl)actamide----1件: 86
3672-[[[(2R)-1-[1-[(4-CHLORO-3-METHYLPHENYL)METHYL]-4- PIPERIDINYL]-5-OXO-2-PYRROLIDINYL]CARBONYL]AMINO]- N,N,6-TRIMETHYL-4-PYRIDINECARBOXAMIDE,DIHYDROCHLORIDE----2件: 6, 162
3682-amino-4-(methyl[11C]sulfanyl)butanoic acid2件: Butyric Acid,
Methionine		1件: D00019 --1件: 34
3692-aminoethanethiol1件: Cysteamine1件: D03634 --2件: 19, 299
3702-CdA1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
3712-CdA, 2-chloro-2'-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
3722-CdA, 2-chloro-2'-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
3732-CdA, 2-chloro-2?-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
3742-CdA, 2-chloro-2?-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
3752-CdA, 2-chloro-2’-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
3762-CdA, 2-chloro-2’-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
3772-chloro-2'-deoxy-beta-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
3782-chloro-2'-deoxy-ß-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
3792-chloro-2'-deoxyadenosine (2-CdA)1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
3802-chloro-2'-deoxyadenosine, 2CdA----1件: 13
3812-chloro-2?-deoxy-beta-D-adenosine1件: Adenosine1件: D00045 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
3822-chloro-2?-deoxy-ß-D-adenosine1件: Adenosine1件: D00045 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
3832-chloro-2’-deoxy-beta-D-adenosine1件: Adenosine1件: D00045 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
3842-chloro-2’-deoxy-beta-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
3852-chloro-2’-deoxy-ß-D-adenosine1件: Adenosine1件: D00045 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
3862-chloro-2’-deoxy-ß-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
3872-chloro-2’-deoxyadenosine (2-CdA)1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
3882-deoxy-2 [F-18] fluoro-2-d-glucose1件: D-glucose1件: D00009 --1件: 49
3892-HOBA1件: 2-(aminomethyl)phenol---1件: 46
3902-Hydroxybenzoic acid1件: Salicylic acid1件: D00097 --1件: 97
3912-HYDROXYPROPYL-BETA-CYCLODEXTRIN2件: Betadex,
Hydroxypropyl betadex		1件: D02401 --1件: 19
3922-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl) acetamide1件: Acetamide---1件: 86
3932-{7-[1,1-dimethyl-3-(4-sulfobutyl)-benz[e]indolin-2-ylidene]-1,3,5-heptatrienyl}-1,1-dimethyl-3-(sulfobutyl)-1H-benz[e]-indolium hydroxide,inner salt1件: Hydroxide ion---1件: 46
3942.0 MIU IL-2 per day1件: Human interleukin-2---1件: 2
39520 mg----1件: 97
39620 mg BID of PF-02545920----1件: 8
39720 mg fampridine-SR (4-aminopyridine, 4-AP)1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
39820 mg GA----1件: 13
39920 mg MitoQ----1件: 13
40020 mg sildenafil citrate by mouth1件: Sildenafil1件: D08514 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86
40120 mg/ml Treprostinil1件: Treprostinil1件: D06213 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
402200 mg BIA 6-5121件: BIA---1件: 6
403200 mg LX3305 QD----1件: 46
404200 mg/m2 dose----1件: 299
405200 µg Brimonidine Tartrate Implant1件: Brimonidine1件: D07540 3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90
406200106 or EMD 28162----1件: 13
407200mg Cannabidiol by capsules twice daily1件: Cannabidiol1件: D10915 2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 46
4082011-2012 seasonal flu vaccine Intramuscular----2件: 3, 113
4092011-2012 seasonal flu vaccine Subcutaneous----2件: 3, 113
410201600930----1件: 2
4112019171-69-6----1件: 61
412207-3120----1件: 6
41320mg daily citalopram1件: Citalopram1件: D07704 1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 8
41420mg/0.5ml GA----1件: 13
41520mg/0.5ml glatiramer acetate2件: Acetate,
Glatiramer		---1件: 13
416225mg SHP647 (PF-00547659)----1件: 97
41723-PPV----1件: 13
41823-valent pneumococcal polysaccharide vaccine----3件: 13, 46, 53
41923-valent pneumococcal polysaccharide vaccine (23-PPV)----1件: 13
42023-valent polysaccharide pneumococcal vaccine----1件: 96
42123-valent polysaccharide pneumococcal vaccine (Pneumovax TM)----2件: 96, 97
4222387066----1件: 56
423240mg Amantadine HCl ER tablets1件: Amantadine1件: D07441 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
42425 mg BIA9 1067----1件: 6
42525 mg Ongentys1件: Opicapone1件: D10825 1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6
42625 mg Ontamalimab1件: Ontamalimab---2件: 96, 97
42725% MTD sodium nitrite inhalation solution1件: Nitrite---1件: 86
42825(OH)D3----1件: 13
42925-Hydroxyvitamin D31件: Calcifediol1件: D00122 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
430250 mg CK-2017357----2件: 2, 11
431250 mg LX3305 BID----1件: 46
432250 mg LX3305 QD----1件: 46
433250mg mesalazine pellets1件: Mesalazine1件: D00377 --1件: 97
43425330----1件: 6
4352593----1件: 46
43625mcg rhPTH(1-84)1件: Parathyroid hormone1件: D05364 2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235
43725OH-Vitamin D1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 13
43826 common Fabry mutation types in Taiwan----1件: 19
4392622U90 Duramycin1件: Lancovutide---1件: 299
44026866138----1件: 28
44129180.00.00, 34681.00.00, 34681.01.00, 34681.02.00----1件: 113
442291844----2件: 246, 299
4432B3-201----1件: 13
4442L polyethylene glycol/ascorbic acid2件: Ascorbic acid,
Polyethylene glycol		2件: D00018 ,
D03370 		--1件: 97
4452mg budesonide effervescent tablet for orodispersible use1件: Budesonide1件: D00246 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98
4462mg KPG-818 dose----1件: 49
4472S,4R-(-)-ketoconazole1件: Ketoconazole1件: D00351 1件: CYP17A1 💬6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬1件: 75
4482S,4R-(-)-ketoconazole, levoketoconazole2件: Ketoconazole,
Levoketoconazole		2件: D00351 ,
D10950 		3件: CYP11A1,
CYP11B1,
CYP17A1 💬		7件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬1件: 75
4493 mg [14C]-A4250 capsule----3件: 93, 297, 338
4503 mg Melatonin1件: Melatonin1件: D08170 2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 13
4513 mg QD to 15 mg QD PF-066497511件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
4523 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study)1件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
4533 mg tropicamide1件: Tropicamide1件: D00397 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6
4543 mg/kg GSK2402968----1件: 113
4553 MPDN pulse + PDN----1件: 50
4563 MPDN pulse + PDN + CSA----1件: 50
4573 MPDN pulse + PDN + MTX----1件: 50
4583 Servings of broccoli sprouts1件: Broccoli---1件: 97
4593,4-DIAMINOPYRIDINE----2件: 12, 13
4603,4-Diaminopyridine Phosphate1件: Phosphate ion---1件: 3
4613- (9,10- Didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate----1件: 6
4623-(3,4-Dihydroxyphenyl)-L-alanine1件: Alanine1件: D00012 --1件: 6
4633-(3-(3,5-DIMETHYL-1H-PYRAZOL-4-YL)PROPOXY)-4-FLUOROBENZOIC ACID1件: Pyrazole---1件: 28
4643-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-----1件: 93
4653-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)pentanedioic acid----1件: 93
4663-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt----2件: 51, 85
4673-hydroxy-2-methyl-4H-pyrane-4-one iron (III) complex (3:1), Ferric (3-hydroxy-2-methyl-4-pyrone), Tris-maltol-iron (III), Tri=maltol-iron (III)1件: Tromethamine1件: D00396 --2件: 96, 97
4683-methyl-1-phenyl-4, 5-dihydro-1H-pyrazol-5-one.1件: Pyrazole---1件: 2
46930 or 60 mg----1件: 67
47030 or 90 mg----1件: 67
471300 mg double-blinded secukinumab1件: Secukinumab1件: D09967 1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 271
472300 mg LX3305 QD----1件: 46
473300mg Gemcabene1件: Gemcabene---1件: 265
4743108006977----1件: 94
475320mg Amantadine HCl ER tablets1件: Amantadine1件: D07441 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
476331731-18-1----4件: 46, 96, 97, 271
4773400930060797----1件: 36
4783400935113276----1件: 56
47935565011----1件: 46
48035mg----2件: 50, 107
48136-482-Hyaluronoglucosaminidase PH20 (rHuPH20)1件: Hyaluronidase3件: D04455 ,
D04456 ,
D06604 		--1件: 65
4823a,7a-dihydroxy-6a-ethyl-5betacholan-24-oic acid----1件: 93
4833a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid----1件: 93
4843K3A-APC Protein----1件: 2
4853TC----2件: 256, 265
4864 cholesten-3-one, oxime----1件: 2
4874 mg perampanel1件: Perampanel1件: D08964 4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬		16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 6
4884 mg/kg CNTO 136----1件: 49
4894 million hMSC/kg----1件: 46
4904% chlorhexidine gluconate liquid skin cleanser1件: Chlorhexidine1件: D07668 --1件: 299
4914'-chloro-2'-cyano-N-(trans-4-hydroxy-4-methylcyclohexyl)-biphenyl-4-sulphonamide----1件: 46
4924'-iodo-4'-deoxydoxorubicin1件: Iodine1件: D00108 --1件: 28
4934-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]-benzamide, methane sulphonic acid salt. AB1010base1件: Methane---1件: 2
4944-[5-(4-methylphenyl)-3-(trifluoromethyl)- 1H-pyrazol-1-yl] benzenesulfonamide1件: Pyrazole---1件: 46
4954-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide1件: Pyrazole---1件: 46
4964-Aminopyridine1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 3, 13
4974-Aminosalicylic acid1件: Aminosalicylic acid1件: D00162 --1件: 96
4984-Aminosalicylic acid extended release granules1件: Aminosalicylic acid1件: D00162 --1件: 96
4994-AP1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
5004-benzyl-2-naphtalen-1-yl-1,2,4-thiadiazolidine-3,5-dione----1件: 5
5014-Benzyl-2-naphthalen-1-yl-1,2,4- thiadiazolidine-3,5-dione----1件: 113
5024-benzyl-2-naphthalen-1-yl-1,2,4-thiadiazolidine-3,5-dione----1件: 113
5034-cholesten-3-one, oxime----2件: 2, 3
5044-cholesten-3-one,oxime----1件: 3
5054-Methylpyrazole1件: Fomepizole1件: D00707 3件: ADH1A,
ADH1B,
ADH1C 💬		9件: Alcoholic liver disease, Drug metabolism - cytochrome P450, Fatty acid degradation, Glycolysis / Gluconeogenesis, Metabolic pathways, Metabolism of xenobiotics by cytochrome P450, Pyruvate metabolism, Retinol metabolism, Tyrosine metabolism 💬1件: 301
5064-PBA----1件: 231
5074-phenylbutyrate1件: Phenylbutyric acid---2件: 251, 299
5084-{[(1R,2s,3S,5s,7s)-5-Hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-b]pyridine-5-carboxamide monohydrobromide----1件: 46
5094.2% NaCl/Inhalation solution----1件: 299
5104.5 mg Naltrexone1件: Naltrexone1件: D05113 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
51140 mg----1件: 96
51240 mg GA----2件: 2, 13
51340 mg glatiramer acetate2件: Acetate,
Glatiramer		---2件: 2, 13
51440 mg Glatiramer acetato1件: Glatiramer---1件: 13
51540 mg MSB11022----5件: 46, 96, 97, 107, 271
51640 mg QD Alogabat----1件: 201
51740 MG- SOLUZIONE INIETTABILE IN SIRINGHE PRE-RIEMPITE- USO SOTTOCUTANEO- SIRINGA PRERIEMPITA (0,4ML)- 2 SIRINGHE PRE-RIEMPITE + 2 TAMPONI IMBEVUTI DI ALCOOL----1件: 107
518400 mg BIA 5-10581件: BIA---1件: 86
519400 mg LX3305 QD----1件: 46
520400 µg Brimonidine Tartrate Implant1件: Brimonidine1件: D07540 3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90
521400mg Cannabidiol by capsules twice daily1件: Cannabidiol1件: D10915 2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 46
52240mg of MitoQ----1件: 13
52342942019----4件: 46, 96, 97, 271
52444/154/85-C----1件: 50
52544/196/81-C----1件: 50
52645 mg sodium nitrite inhalation solution1件: Nitrite---1件: 86
527450 mg Induction/Chronic----1件: 97
5284AU76----1件: 86
5294cc of lidocaïne®----1件: 149
5304D-125 IVT Injection----1件: 90
5314D-310----1件: 19
5324D-710----1件: 299
5335 ASA, enemas, suppositories, corticosteroids----1件: 97
5345 mg Melatonin1件: Melatonin1件: D08170 2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 13
5355 mg Montelukast1件: Montelukast1件: D08229 1件: CYSLTR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 98
5365 mg Prednisone1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 44
5375% glucose water solution2件: Dextrose, unspecified form,
Water		1件: D00001 --1件: 2
5385% lidocaine/5 mg/ml 0.02% estradiol compound cream2件: Estradiol,
Lidocaine		3件: D00105 ,
D00358 ,
D08127 		7件: ESR1,
ESR2,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		13件: Adrenergic signaling in cardiomyocytes, Breast cancer, Chemical carcinogenesis - receptor activation, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway 💬1件: 226
5395% sildenafil cream1件: Sildenafil1件: D08514 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 50
5405,6,7,8-tetrahydrobiopterin1件: Sapropterin1件: D08505 --1件: 240
5415-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole----1件: 113
5425-[4-[2-(5-(1-hydroxyethyl)-2- pyridinyl)ethoxy]benzyl]-2,4- thiazolidinedione hydrochloride1件: 2,4-thiazolidinedione---1件: 20
5435-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride1件: 2,4-thiazolidinedione---1件: 20
5445-[[4-[2-[5-(1-HYDROXYETHYL)-2-PYRIDINYL]ETHOXY]PHENYL]METHYL]-2,4-THIAZOLIDINEDIONE HYDROCHLORIDE1件: 2,4-thiazolidinedione---1件: 20
5455-ALA1件: Aminolevulinic acid1件: D07567 --1件: 180
5465-amino salicylic acid1件: Salicylic acid1件: D00097 --1件: 97
5475-amino salicylic acid (5-ASA)2件: Mesalazine,
Salicylic acid		2件: D00097 ,
D00377 		--1件: 97
5485-amino-2-hydroxybenzoic acid1件: Salicylic acid1件: D00097 --1件: 97
5495-aminolevulinic acid1件: Aminolevulinic acid1件: D07567 --1件: 96
5505-Aminosalicyclic acid----1件: 97
5515-Aminosalicyl acid----1件: 96
5525-aminosalicylate (Pentasa, Ferring)----2件: 96, 97
5535-Aminosalicylic acid2件: Aminosalicylic acid,
Mesalazine		2件: D00162 ,
D00377 		--2件: 96, 97
5545-Aminosalicylic acid (5-ASA)2件: Aminosalicylic acid,
Mesalazine		2件: D00162 ,
D00377 		--1件: 97
5555-ASA1件: Mesalazine1件: D00377 --1件: 97
5565-ASA (5-Aminosalicylate)1件: Mesalazine1件: D00377 --1件: 97
5575-ASA MMx1件: Mesalazine1件: D00377 --1件: 97
5585-Chlor-6'-methyl- 3-[4-(methylsulfonyl)phenyl]- 2,3'-bipyridin1件: Chlorine---2件: 46, 271
5595-Chloro-1,2-dihydro-N-ethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-3-quinolinecarboxamide sodium----1件: 8
5605-HTP----2件: 96, 97
5615-Hydroxytryptophan / Vitamin B61件: Pyridoxine1件: D08454 --1件: 206
5625-Methyl-1-Phenyl-2-1-(H)-Pyridone----1件: 228
5635-methyltetrahydrofolate and vitamin B121件: Cyanocobalamin4件: D00166 ,
D03615 ,
D03616 ,
D03617 		--1件: 299
5645-MTHF----1件: 337
5655-probe cocktail----1件: 254
56650 mg----1件: 97
56750 mg AP1189----1件: 46
56850 mg BIA 9 10671件: BIA---1件: 6
56950 mg ELX/25 mg TEZ/37.5 mg IVA----1件: 299
57050 mg ELX/25 mg TEZ/37.5 mg IVA fixed dose combination----1件: 299
57150 mg Etanercept1件: Etanercept1件: D00742 2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
57250 mg Induction/Chronic----1件: 97
57350 mg LX3305 QD----1件: 46
57450 mg Ongentys1件: Opicapone1件: D10825 1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6
575500 0500 0----1件: 19
576500 mg CK-2017357----2件: 2, 11
577500 mg LX3305 QD----1件: 46
5785000 IU D3----1件: 96
5795000 IU of cholecalciferol1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
5805000IU vitamin D1件: Vitamin D---1件: 13
5815009111000001105----1件: 43
582500mg mesalazine pellets1件: Mesalazine1件: D00377 --1件: 97
583500mg RTX Group----1件: 46
5845057732----1件: 271
58550mcg rhPTH(1-84)1件: Parathyroid hormone1件: D05364 2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235
58652069.00.01----1件: 13
587534-1508----1件: 85
588549-0261/F02-01----2件: 96, 97
589552-02----2件: 53, 299
59056/104/75-C----1件: 50
5915mg----2件: 50, 107
5926 alpha-ethylchenodeoxycholic acid (6-EDCA), OCA, INT-747----1件: 93
5936 Mercaptopurine1件: Mercaptopurine2件: D00161 ,
D04931 		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬2件: 96, 97
5946 mg/kg GSK2402968----1件: 113
5956 million hMSC/kg----1件: 46
5966% Hypertonic Saline (HS), 4mL----1件: 299
5976-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine----1件: 38
5986-(nitrooxy)hexyl(2Z)-4-(acetyloxy)-3-[4-(methylsulfonyl)phenyl]-2-phenylbut-2-enoate----1件: 46
5996-[(methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-purine----1件: 96
6006-[18F]Fluorodopa----1件: 6
6016-[18F]Fluorodopamine----1件: 6
6026-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid----1件: 97
6036-ECDCA1件: Obeticholic acid1件: D09360 1件: NR1H4 💬1件: Bile secretion 💬1件: 93
6046-ethylchenodeoxycholic acid1件: Obeticholic acid1件: D09360 1件: NR1H4 💬1件: Bile secretion 💬1件: 93
6056-ethynyl-1-(pentan-3-yl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one----1件: 2
6066-Mercaptopurine1件: Mercaptopurine2件: D00161 ,
D04931 		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬3件: 96, 97, 164
6076-Mercaptopurine (Puri-Nethol)1件: Mercaptopurine2件: D00161 ,
D04931 		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 96
6086-MP1件: Mercaptopurine2件: D00161 ,
D04931 		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬2件: 96, 97
60960 mg QD Alogabat----1件: 201
610600mg Gemcabene1件: Gemcabene---1件: 265
6116036937.00.01----1件: 6
61264Cu]Cl2----1件: 171
61364CuCl2----1件: 171
61466215-101----1件: 86
615683699----1件: 96
61668Ga-BMV101----1件: 85
61768Ga-BNOTA-PRGD2----1件: 46
61868Ga-DOTANOC----1件: 84
61968Ga-DOTATATE2件: Dotatate,
Dotatate gallium Ga-68		---1件: 84
62068Ga-DOTATATE PET/CT2件: Dotatate,
Dotatate gallium Ga-68		---1件: 84
62168Ga-FAPI----2件: 46, 300
62268Ga-NEB----3件: 46, 89, 280
62368GaNOTA-Anti-MMR-VHH2----1件: 84
6246?-ethylchenodeoxycholic acid (6-ECDCA), OCA, INT-7471件: Obeticholic acid1件: D09360 1件: NR1H4 💬1件: Bile secretion 💬1件: 93
6256a-ethylchenodeoxycholic acid (6-ECDCA), OCA, INT-7471件: Obeticholic acid1件: D09360 1件: NR1H4 💬1件: Bile secretion 💬1件: 93
6266a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid1件: Obeticholic acid1件: D09360 1件: NR1H4 💬1件: Bile secretion 💬1件: 93
6276a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o1件: Obeticholic acid1件: D09360 1件: NR1H4 💬1件: Bile secretion 💬1件: 93
6286a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o, obeticholic acid (OCA)1件: Obeticholic acid1件: D09360 1件: NR1H4 💬1件: Bile secretion 💬1件: 93
6296a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o1件: Obeticholic acid1件: D09360 1件: NR1H4 💬1件: Bile secretion 💬1件: 93
6306a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o, obeticholic acid (OCA)1件: Obeticholic acid1件: D09360 1件: NR1H4 💬1件: Bile secretion 💬1件: 93
6316a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid1件: Obeticholic acid1件: D09360 1件: NR1H4 💬1件: Bile secretion 💬1件: 93
6326a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o1件: Obeticholic acid1件: D09360 1件: NR1H4 💬1件: Bile secretion 💬1件: 93
6336a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o , obeticholic acid (OCA)1件: Obeticholic acid1件: D09360 1件: NR1H4 💬1件: Bile secretion 💬1件: 93
6346a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o1件: Obeticholic acid1件: D09360 1件: NR1H4 💬1件: Bile secretion 💬1件: 93
6356a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o , obeticholic acid (OCA)1件: Obeticholic acid1件: D09360 1件: NR1H4 💬1件: Bile secretion 💬1件: 93
6366abeta - apomorphine-10,11-diol hydrochloride hemihydrate1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
6376aß - apomorphine-10,11-diol hydrochloride hemihydrate1件: Apomorphine1件: D07460 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
6386R-BH41件: Sapropterin1件: D08505 --3件: 86, 124, 240
6397 mg QD Alogabat----1件: 201
6407 mg QD to 15 mg QD PF-066497511件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
6417 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study)1件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
6427% Hypertonic Saline (HS)----1件: 299
6437% NaCl----1件: 299
6447% saline----1件: 299
6457-beta-Hydroxyepiandrosterone1件: 7-beta-Hydroxyepiandrosterone---1件: 6
6467-valent Pneumococcal Conjugate vaccine----1件: 46
64770930.00.00----1件: 46
64875----1件: 6
64975 mg Ontamalimab1件: Ontamalimab---2件: 96, 97
65075-mg IVACAFTOR1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
651750 mg metformin and 7.5 g L-citrulline daily p.o.2件: Citrulline,
Metformin		1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113
652750mg mesalazine pellets1件: Mesalazine1件: D00377 --1件: 97
65375mg CXA-101件: CXA-10---1件: 86
65475mg SHP647 (PF-00547659)----1件: 97
6558-OHdG1件: 8-hydroxy-2'-deoxyguanosine---1件: 6
65680 mg DR-6MP----1件: 96
657800 mg ibuprofen/26.6 mg famotidine2件: Famotidine,
Ibuprofen		2件: D00126 ,
D00318 		3件: HRH2,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 107
65880mg ELX / 40mg TEZ / 60mg IVA----1件: 299
65981mg aspirin1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 49
6608594739041288----1件: 46
6618699505952864----1件: 56
66289 Zirconium Recombinant Human Alpha-N-Acetylglucosaminidase (rhNAGLU) (radiolabeled)----1件: 19
66389ZR-BEVACIZUMAB2件: Bevacizumab,
Bevacizumab zirconium Zr-89		1件: D06409 1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 34
66489Zr-DFO-CZP----1件: 46
66589Zr-SBC-103----1件: 19
66689Zr]Zr-Df-crefmirlimab berdoxam----2件: 51, 53
6679 mg/kg GSK2402968----1件: 113
6689-Chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo[2,3-b] quinoxaline----1件: 46
6699-CIS, 12-CIS-11,11-D2-LINOLEIC ACID ETHYL ESTER1件: Linoleic acid---2件: 2, 5
67090 mg hydrocortisone acetate suppository with Sephure suppository applicator2件: Acetate,
Hydrocortisone		1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97
67190 mg idrocortisone acetato in supposta con appli----1件: 97
67290 mg idrocortisone acetato in supposta con applicatore per supposte Sephure----1件: 97
67390 mg sodium nitrite inhalation solution1件: Nitrite---1件: 86
6749060X----2件: 13, 149
67595% Pure ECGC capsules 200mg----1件: 13
6769512----1件: 46
6779715X----1件: 90
6789741X----1件: 90
6799742X----1件: 90
68098% dehydrated alcohol1件: Ethanol1件: D06542 --1件: 298
68198-92-0----1件: 107
68299m technetium infliximab1件: Infliximab1件: D02598 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 84
68399mTc-3PRGD2----1件: 46
68499mTc-Infliximab1件: Infliximab1件: D02598 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 84
68599mTc-rhAnnexin V-128----2件: 46, 271
68699mTc-S-HYNIC Certolizumab pegol1件: Certolizumab pegol1件: D03441 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96
687: 2-{4-[(5,6-difenilpirazin-2-yl)(isopropil)amino]butoxi}-N-----1件: 86
688: immunoglobulina umana normale 10% per somministrazione endovenosa----1件: 14
689?-3 polyunsaturated fatty acid----1件: 96
690[11C]-GSK2256098 500 MBq1件: GSK2256098---1件: 86
691[11C]-PIB----1件: 6
692[11C]MPC6827----1件: 2
693[11C]PXT012253----1件: 6
694[123I] 5-IA----1件: 6
695[123I] IBVM and SPECT imaging----1件: 6
696[123I] mZINT injection and serial dynamic SPECT imaging----1件: 6
697[123I]-IBVM----1件: 6
698[123I]B-CIT----1件: 6
699[123I]B-CIT SPECT imaging----1件: 6
700[123I]beta CIT----1件: 6
701[123I]beta CIT and SPECT imaging----1件: 6
702[123I]beta-CIT----1件: 6
703[123I]beta-CIT and SPECT imaging----1件: 6
704[123I]CLINDE----2件: 6, 13
705[123I]MNI-420----2件: 6, 8
706[123I]ß CIT----1件: 6
707[123I]ß CIT and SPECT imaging----1件: 6
708[123I]ß-CIT----1件: 6
709[123I]ß-CIT and SPECT imaging----1件: 6
710[124I]IB PF 06687234----2件: 96, 97
711[14C] AT1001----1件: 19
712[14C]-BIA 9-10671件: BIA---1件: 6
713[15-O]water1件: Water1件: D00001 --1件: 206
714[18F] CFPyPB----1件: 6
715[18F] FES----1件: 86
716[18F] GE-180----1件: 2
717[18F] LBT-999 PET----1件: 6
718[18F] PBR06----2件: 6, 13
719[18F] PI-2620----1件: 6
720[18F]-FBA-A20FMDV2----1件: 85
721[18F]-FEPPA----2件: 6, 13
722[18F]-FLT-PET/CT scans----1件: 34
723[18F]-PI2620----1件: 5
724[18F]DPA-714 PET----1件: 2
725[18F]DPA-714 PET scan----1件: 6
726[18F]FDOPA----2件: 6, 17
727[18F]FDOPA PET/CT----1件: 6
728[18F]Florbetaben----1件: 28
729[18F]Florbetapir----1件: 5
730[18F]Florbetapir PET imaging----1件: 13
731[18F]flumazenil1件: Flumazenil1件: D00697 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 206
732[18F]Fluoro-2-deoxy-2-D-glucose1件: D-glucose1件: D00009 --2件: 86, 88
733[18F]FP-R01-MG-F2----2件: 85, 94
734[18F]FPEB----3件: 6, 8, 206
735[18F]FPEB PET imaging----1件: 206
736[18F]FSPG----2件: 96, 97
737[18F]MK-9470----1件: 6
738[18F]MNI-1126----1件: 6
739[18F]MNI-815 (MNI-815)----1件: 5
740[18F]MNI-952----1件: 5
741[18F]MNI-958----1件: 5
742[18F]MPPF----1件: 6
743[18F]P17-059----1件: 6
744[18F]PBR06----1件: 2
745[18F]PI-2620----2件: 6, 127
746[18F]T807 ([18F]MNI-777)----2件: 5, 6
747[18F]UCB-2897----1件: 6
748[21CFR640.30] Plasma from 18 - 25 year old volunteer donors----1件: 6
749[68Ga]CBP8----1件: 85
750[68Ga]Ga-PentixaFor PET/CT----1件: 84
751[C-11]Methylreboxetine----1件: 13
752[C-11]PBR28----1件: 13
753[C11]PK-1195 PET scan----1件: 13
754[F-18]PBR06----1件: 13
755[F-18]SDM-8----1件: 13
756[F18]-FDDNP----1件: 5
757[Zr-89]Oxine-labeled leukocytes PET/MRI1件: Oxyquinoline1件: D05321 --1件: 13
758 LNP023 HYDROCHLORIDE SALT----5件: 61, 62, 66, 109, 222
759ÁCIDO GADOBÉNICO----1件: 96
760Ácido risedrónico----1件: 274